Helen Tesfaye News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones. In a study led by investigators from <a href="https://www.massgeneralbrigham.org/" target=" blank">Mass General Brigham</a>, researchers found that there was an association between the use of sodium-glucose contratransporter 2 (SGLT2) inhibitors and a lower risk of developing kidney stones. Their findings are reported in <a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2814491?utm campaign=articlePDF&amp;utm medium=articlePDFlink&amp;utm source=articlePDF&amp;utm content=jamainternmed.2023.7660" target=" blank">JAMA Internal Medicine</a>.&nbsp;</p>

United statesGaryc curhanJulie paikHelen tesfayeDeborahj wexlerHeidi zakoulMethod of researchDrug administrationOutcomes research instituteDivision of renal kidney medicine at brighamNational institute of agingBoehringer ingelheimDepartment of medicineDivision of pharmacoepidemiologyNational institute of arthritisHarvard medical school